HopeStage
Back to all studies
RecruitingNCT06073470

Metabolic and brain-signal changes during methylphenidate treatment for ADHD in children

About this titleRead the official source — NCT06073470
Observational studyAges 6–18Taiwan
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 18 years.

Listed locations
TaipeiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
160
Sponsor
National Taiwan University Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Drug
Locations
Taiwan
Age range
From 6 Years to 18 Years
Official registry ID
NCT06073470
Official title
Show the full official title

Exploration of the Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With Attention-Deficit/Hyperactivity Disorder

Recruitment & locations

Currently recruiting

Taipei

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Taiwan University Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including methylphenidate.

Who can participate?

Listed age limits: 6 years to 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies